25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression
Background. There are several circulatory biomarkers that are involved in forecasting the clinical outcome of cutaneous melanoma. Serum/plasma vitamin D status is one of the markers intensively studied in this type of cutaneous cancer. The combination of validated serum biomarkers (like LDH) with ne...
Saved in:
| Main Authors: | Corina-Daniela Ene, Amalia-Elena Anghel, Monica Neagu, Ilinca Nicolae |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/904876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression
by: D. Е. Frolova, et al.
Published: (2023-01-01) -
Relationship between 25(OH)D2, 25(OH)D3 and core symptoms in autism spectrum disorder
by: Liu Jia, et al.
Published: (2025-08-01) -
Comparison of serum level of 25(OH) vitamin D3 in brucellosis patients with healthy persons in Hamadan, west of Iran
by: Fariba Keramat, et al.
Published: (2018-06-01) -
Matrix metalloproteinases as diagnostic and prognostic biomarkers in skin cutaneous melanoma and squamous cell carcinoma
by: Jingya Hei, et al.
Published: (2025-07-01) -
The relationship between 1,25(OH)D levels and interleukin-32 and vascular endothelial growth factor levels in endometriosis cyst tissue: An original article
by: Mirza Ismail, et al.
Published: (2025-04-01)